Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Cancer Genetics Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.67M 2.52M 3.02M 4.3M 6.61M
Cost of Goods Sold (COGS) incl. D&A 2.53M 3.52M 3.12M 3.93M 4.92M
COGS excluding D&A 2.22M 3.19M 2.75M 3.58M 4.6M
Depreciation & Amortization Expense 307,012 326,818 369,651 353,405 326,476
Depreciation 303,771 317,095 356,603 338,176 311,247
Amortization of Intangibles 3,241 9,723 13,048 15,229 15,229
Gross Income (865,931) (994,610) (98,004) 372,570 1.69M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 3.42M 5.33M 8.09M 8.01M 9.53M
Research & Development 1.34M 1.17M 2.07M 2.11M 2.19M
Other SG&A 2.08M 4.16M 6.01M 5.9M 7.34M
Other Operating Expense 0 0 0 0 0
Unusual Expense 953,000 1.29M 10.39M (5.68M) 2.83M
EBIT after Unusual Expense (953,000) (1.29M) (10.39M) 5.68M (2.83M)
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 2,514 763 117 - 29,693
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 2.09M 792,415 1.31M 4.7M 2.39M
Gross Interest Expense 2.09M 792,415 1.31M 4.7M 2.39M
Interest Capitalized 0 0 0 0 0
Pretax Income (7.33M) (8.41M) (19.89M) (6.67M) (13.04M)
Income Tax 0 0 0 0 (663,900)
Income Tax - Current Domestic 0 0 0 0 -
Income Tax - Current Foreign 0 0 0 0 -
Income Tax - Deferred Domestic 0 0 0 0 -
Income Tax - Deferred Foreign 0 0 0 0 -
Income Tax Credits 0 0 0 0 -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) - - - - 0
Consolidated Net Income (7.33M) (8.41M) (19.89M) (6.67M) (12.37M)
Minority Interest Expense 0 0 0 0 0
Net Income (7.33M) (8.41M) (19.89M) (6.67M) (12.37M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (7.33M) (8.41M) (19.89M) (6.67M) (12.37M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (7.33M) (8.41M) (19.89M) (6.67M) (12.37M)
EPS (Basic) (0.58) (2.09) (4.95) (1.66) (2.65)
Basic Shares Outstanding 12.71M 4.02M 4.02M 4.02M 4.67M
EPS (Diluted) (0.58) (2.09) (4.95) (3.54) (3.64)
Diluted Shares Outstanding 12.71M 4.02M 4.02M 4.02M 4.68M
EBITDA (3.98M) (6M) (7.82M) (7.29M) (7.52M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.